We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Report shows 300% increase in demand for GLP-1 weight loss and diabetes drugs
Paris is moving slower than other EU capitals in curbing its budget deficit and public debt
Two dozen former employees say engineering firm took uncompromising measures to ensure staff returned to UK campus
The latest findings build on experiments from over a century ago
Brussels launches talks for mRNA jabs to augment existing contract with BioNTech/Pfizer
London’s second-busiest airport to impose cap on departures and arrivals for rest of week
Addressing this IP issue is crucial to ensuring pharmaceutical products are available in future emergencies
Big-selling molnupiravir treatment produces permanent mutations that can be passed from patient to patient
There are reasons to believe the economy is primed to deliver robust and durable expansion over the longer term
Biden-era spending has turbocharged growth — but the resulting debts may bring pain
Non-performing loans look to be on the rise again
The nature of people’s debts have changed significantly — so too must debt solutions
Voters want state to be responsible for controlling prices and reducing inequality
Backlash from business as Pension Protection Fund’s reserves swell to more than £12bn
Tedros Adhanom Ghebreyesus says health body is ready to send second mission as Omicron variants drive rise in cases
Also in this newsletter: UK steel deal, Beijing bites back on electric cars, science round-up
Climate change helps the spread of infectious diseases. Plus: rise in fungal infections highlights risks of antimicrobial resistance; Sydney shows how to almost eliminate HIV transmission; wait goes on for effective Long Covid treatments
Unlike the vaccine race, there is limited funding to treat a condition that is often debilitating
Policymakers are failing to address the likelihood of another pandemic
Rule changes have led to increasing numbers of freelancers joining unregulated schemes
Despite progress on a flu jab, the biotech group will be lossmaking for the next three years
The stock price has fallen by more than 40% despite rising flyer volume
They bring up babies, care for the elderly, walk dogs, cook and clean — but many are tiring of the long hours and low wages
At least three descendants of Omicron have scientists on alert and vaccination programmes speeding up
Lives of 2mn mothers and babies could be saved by 2030 with small innovations in care, says Gates Foundation
International Edition
